Search results

20 items matching your search terms.
Filter the results.
Item type













New items since



Sort by relevance · date (newest first) · alphabetically
Subgroup of women with HER-2-positive breast cancer highly sensitive to treatments, study finds
A UNC Lineberger-led study published in the Journal of Clinical Oncology identified a group of women with HER2 positive breast cancer who could benefit from less intensive targeted treatment
Located in News
Located in Newsroom / UNC Lineberger in the News
Menopausal status may be more important than age in breast cancer screening frequency, study finds
A study published in JAMA Oncology found that pre-menopausal women who were diagnosed with breast cancer following a biennial screening mammogram were likely to have more advanced tumors than woman screened annually. UNC Lineberger researcher Louise Henderson was a co-author on the study, which was co-led by researchers at the University of California-Davis School of Medicine and the Dana-Farber Cancer Institute.
Located in Newsletters / / Honors and Awards / 2015
Genomic analysis paves way for personalized treatment of invasive lobular carcinoma
UNC Lineberger Comprehensive Cancer Center researchers helped lead an effort by The Cancer Genome Atlas Network of researchers to map the genetic drivers of invasive lobular carcinoma, the second most commonly diagnosed invasive form of breast cancer. They found that this cancer type may be at least three different diseases that differ in their microenvironmental features and outcomes.
Located in News
Providing hope and healing through health
Even in the midst of treatment, many cancer patients are finding that exercise helps them to feel better, both physically and emotionally. Through the Get Real & Heal program, UNC researchers are digging deeper into the science behind why moving more can make a positive impact on patients' overall health and well-being.
Located in News
Rock stars for a day
As a breast cancer survivor, Barbara Martin has established a tradition – walking 39 miles to raise awareness and funds for breast cancer – that has become very special to her. This challenge became even more special this year, as her mother and daughter were both by her side along the way.
Located in News
Amy Charney
Amy Charney had already registered to run the 2015 Boston Marathon when she was told she had breast cancer. But not even that diagnosis and active treatment would keep her from crossing the finish line in her hometown of Boston.
Located in Patient Stories / Patient Stories Gallery / Breast Cancer
Who says you can’t go home?
Amy Charney had already registered to run the 2015 Boston Marathon when she was told she had breast cancer. But not even that diagnosis and active treatment would keep her from crossing the finish line in her hometown of Boston.
Located in News
Potential drug target identified for aggressive breast cancer type
In a new pre-clinical study published today, UNC Lineberger researchers show that they can exploit cancer’s reliance on a particular protein to help fight triple negative breast cancer. They believe the protein could be a potential new drug target.
Located in News
Early menarche may be important in development of aggressive breast cancer in African-American women
A multicenter research team known as the African American Breast Cancer Epidemiology and Risk Consortium (AMBER), which includes UNC Lineberger's Andrew Olshan, PhD has uncovered differences in ER-positive & ER-negative breast cancer pathways. The team examined whether relationships between age at menarche and breast cancer are the same for tumors that are ER-positive or ER-negative, particularly among African-American women. ER-negative breast cancer is generally more aggressive and known to be associated with a poorer prognosis than ER-positive disease.
Located in News